SBTX Stock Price, Chart, Stats & News

SkinBioTherapeutics Plc
Save
SkinBioTherapeutics Plc (SBTX) does not currently pay a dividend.
24.62M
Market cap
–
Current P/E
–
Forward P/E
SBTX chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
SkinBioTherapeutics Plc is a life sciences enterprise dedicated to enhancing human health through the exploration and development of technologies that harness the power of the human microbiome. The company has developed two primary technological platforms: SkinBiotix: This innovative solution is designed to strengthen the skin's natural barrier, offer protection against infections, and promote the repair of damaged skin. AxisBiotix: Focusing on the intricate link between gut health and skin conditions, this technology aims to mitigate the symptoms experienced by individuals with psoriasis.
Similar securities
Based on sector and market capitalization
Report issue





